What happens when you take probiotics with antifungals?
Probiotics come in two very different forms, and antifungal drugs treat them very differently. The conflict applies to one type and spares the other.
- Probiotics split into two categories. Bacterial probiotics include Lactobacillus, Bifidobacterium, and Streptococcus thermophilus. Yeast-based probiotics are dominated by Saccharomyces boulardii, the live yeast in products such as Florastor.
- Antifungals are built to kill yeast. A systemic antifungal — fluconazole, itraconazole, voriconazole, posaconazole, amphotericin B, or an echinocandin — acts on Saccharomyces boulardii in much the same way it acts on pathogenic Candida, because S. boulardii is itself a live yeast.
- The yeast probiotic loses viability. Taking a yeast probiotic during antifungal therapy can kill the organism before it establishes in the gut, so the product is less likely to deliver its intended benefit.
- Bacterial probiotics are not directly affected. Bacteria have different cell walls and metabolism, so azole antifungals do not target them. Some Lactobacillus strains have even been studied as adjuncts to fluconazole for recurrent vaginal candidiasis.
Why is this important?
People often reach for probiotics during exactly the conditions that lead to antifungal prescriptions — recurrent thrush, vaginal yeast infections, or Candida overgrowth after antibiotics. Taking Saccharomyces boulardii alongside an antifungal feels intuitive but works against itself: one product is taken to suppress yeast while the other is a yeast.
There is also a safety consideration. CDC Emerging Infectious Diseases has documented Saccharomyces boulardii fungemia (bloodstream infection from the probiotic yeast) in vulnerable patients — particularly those who are immunocompromised or who have a central venous catheter. In that setting a live yeast probiotic is best avoided regardless of antifungal use.
For bacterial probiotics the picture is more reassuring. Lactobacillus and Bifidobacterium are generally not affected by azole antifungals, and laboratory work suggests bacterial strains may even help hold Candida in check rather than working against the drug.
What should you do?
The practical approach is to identify which kind of probiotic you take and time things sensibly around your antifungal course.
Before any change: Tell your doctor or pharmacist every probiotic and supplement you take, and read labels — some multi-strain blends include a yeast component alongside bacteria. If you are immunocompromised, on chemotherapy, or have a central venous catheter, raise this specifically.
Every day while on a systemic antifungal: Pause any product containing Saccharomyces boulardii or S. cerevisiae var. boulardii. If you take a bacterial-only probiotic (Lactobacillus, Bifidobacterium, Streptococcus, or Bacillus), you can usually continue it; some clinicians suggest taking it a few hours apart from the antifungal dose as a simple precaution. Topical antifungals such as clotrimazole or terbinafine cream do not require stopping oral probiotics, because there is no meaningful systemic exposure.
After the antifungal course ends: Resume your yeast probiotic only once therapy is finished and your prescriber agrees. Review with your doctor or pharmacist before restarting.
Which specific products are affected?
Yeast probiotic products to pause include Florastor, DiaResQ, and any supplement listing Saccharomyces boulardii or S. cerevisiae var. boulardii as an ingredient.
Antifungals of concern are the systemic ones: azoles (fluconazole, itraconazole, voriconazole, posaconazole, ketoconazole), polyenes (amphotericin B, and nystatin when used systemically), and echinocandins (caspofungin, micafungin, anidulafungin).
Bacterial-only products — common multi-strain blends containing Lactobacillus, Bifidobacterium, Streptococcus, or Bacillus, and yogurt-based products — are generally compatible with antifungal therapy.
The science behind it
The interaction rests on a small but consistent evidence base.
- A CDC Emerging Infectious Diseases case series and review (Rannikko et al., 2021) documented bloodstream and other invasive infections caused by Saccharomyces boulardii probiotic supplements, predominantly in patients with central venous catheters or who were otherwise vulnerable. This anchors the safety concern about taking a live yeast probiotic in at-risk patients.
- An in-vitro (laboratory) study (Suchodolski et al., Scientific Reports, 2021; PMID 33753842) found that capric acid secreted by S. boulardii alters how Candida albicans responds to fluconazole and amphotericin B — confirming a real biological interaction between the yeast probiotic and these antifungals at the cellular level, though it has not been tested in people.
Both the mechanism (an antifungal kills a live yeast) and the documented fungemia risk in catheter and immunocompromised patients support pausing yeast probiotics during systemic antifungal therapy while continuing bacterial strains.
Frequently Asked Questions
Do I need to stop all probiotics during antifungal treatment?
No. The concern is specific to yeast-based probiotics like Saccharomyces boulardii. Bacterial probiotics (Lactobacillus, Bifidobacterium) are generally unaffected and can usually be continued.
How do I know if my probiotic contains yeast?
Read the ingredient list. Look for Saccharomyces boulardii or S. cerevisiae var. boulardii. Florastor and DiaResQ are common yeast-based products. Some multi-strain blends add a yeast alongside bacteria, so check carefully.
What about an antifungal cream or vaginal suppository?
Topical antifungals such as clotrimazole or terbinafine cream act locally and are not meaningfully absorbed, so they do not require stopping an oral probiotic.
Can a bacterial probiotic and an antifungal be taken together?
Usually yes. If you prefer extra caution, some clinicians suggest taking the bacterial probiotic a few hours apart from the antifungal dose. Ask your prescriber what they advise.
I'm immunocompromised or have a central line — what's different for me?
Avoid Saccharomyces boulardii entirely, regardless of antifungal use, because of the documented risk of fungemia in these groups. Discuss any probiotic with your care team first.
When can I restart my yeast probiotic?
Once your antifungal course is complete and your prescriber agrees. Review with your doctor or pharmacist before restarting.
Key takeaways
- Systemic antifungals can kill yeast probiotics (Saccharomyces boulardii), blunting their benefit; pause them during therapy.
- Bacterial probiotics (Lactobacillus, Bifidobacterium) are generally unaffected and may be continued.
- Switching to a bacterial-only blend is the simplest way to keep some probiotic coverage during treatment.
- Topical antifungals do not require stopping oral probiotics.
- If you are immunocompromised or have a central venous catheter, avoid S. boulardii entirely.
- Review with your doctor or pharmacist before stopping or restarting any product.